Account
Articles
26.05.2021
Better internal communications

4 ways to improve market access through communication

Read more
Articles
12.04.2021
Benefits of early dialogue with HTA

Remap Consulting has significant expertise in guiding companies through both EUnetHTA / EMA Parallel...

Read more
Articles
29.03.2021
What is Relative Effectiveness Assessment

Relative Effectiveness Assessment (REA) is a type of assessment that evaluates the effectiveness of ...

Read more
Publications
19.11.2020
ISPO 2020 Developing a sustainable biosimilar

To facilitate biosimilar uptake, several mechanisms aimed at reducing the acquisition cost of biosim...

Read more
Publications
19.11.2020
COVID-19 impact on HTA bodies

HTA bodies and companies within the pharmaceutical industry have been forced to react to unprecedent...

Read more
Publications
19.11.2020
ISPOR 2020 New NICE STA process

This study aimed to assess whether the new process has resulted in changes to outcomes of STAs.

Read more
Articles
05.05.2020
Remote delivery of market access training

Whilst many businesses are currently working remotely, up-skilling your workforce through interactiv...

Read more
Articles
05.03.2020
Access to orphan drugs in the EU

Differences in market access and reimbursement processes are an important factor in determining the ...

Read more
Publications
06.11.2019
Pricing and market access launch excellence

Pharmaceutical companies are incorporating payer / HTA needs into their clinical and commercial laun...

Read more
Articles
31.07.2019
Commercial patient access scheme

In England, to gain a positive recommendation for use within the NHS from NICE, pharmaceutical produ...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.